Bio-Modeling Systems: The Mechanisms-Based Mecidicine Company
  • 2017: PRESS-RELEASE: Paris-November 16, 2017:BMSystems is selected to pitch at the “Translational Neurosciences Conference” organized by “NeurATRIS” and supported by “eartis” the European Infrastructure For Translational Medicine, comprising more than 80 leading European Institutes.

  • 2017: PRESS-RELEASE: Paris-New-York October 4, 2017: BMSystems, with its 14 independently validated successes to date, is selected by the Galien Foundation for the MedStartUp Award 2017 program first step during the US Galien Prize Forum in New-York.
     
  • 2017: ANNOUNCEMENT: Latest news:  Press-release from Hospices Civils de Lyon about phage therapy success with Pherecydes Pharma bacteriophages. Pherecydes-Pharma, is BMSystems’ first therapeutic spin-off.
     
  • 2017: ANNOUNCEMENT: Paris September 7, 2017: The future of Medicine: Bio-Modeling Systems invited to present at the Summer Universities of Fédération Hospitalière de France
     
  • 2017: ANNOUNCEMENT: Belgium August 26-27, 2017: BMSystems selected to meet Wallonia life Sciences Companies and is invited to the Spa-Francorchamps Formula 1 Race. Great place for top meeting!

  • 2017: ANNOUNCEMENT: Paris July 4, 2017. BMSystems was invited to present at the Conference INSEAD Alumni at BCG Paris Office: Everything you always wanted to know about Digital Health revolution “big promises” but were afraid to ask!

  • 2017: ANNOUNCEMENT: Paris January 17, 2017: BMSytems was invited at the France-India healthcare Summit to present its Computer Augmented Deductive Intelligence platform and its operational successes

  • 2017: ANNOUNCEMENT: Paris January 17, 2017: BMSytems invited to present its collaborative success story with CEA life Sciences at the 10 years anniversary of Medicen Paris Region Health cluster

  • 2017: Happy New Year: Our 8 Resolutions for 2017 to be ready for the upcoming bubble explosion! - Bonne Année: Nos 8 Résolutions pour 2017
     
  • 2016: INTERVIEW (Post LinkedIn FR avec explications): "Drug Discovery and health Big Data. The enormous Bubble will explode.” (Post LinkedIn ENG with all the explanations)  Manuel GEA, CEO of BMSystems in Biotech & Finances the leading biotech sector information letter

  • 2016: ANNOUNCEMENT: Paris October 5, 2016: BMSystems' CEO invited to present its digital-biology strategy and achievements at the inaugural session of Medicen Paris Region 10th years anniversary

  • 2016: PRESS RELEASE: Paris September 5, 2016: BMSystems selected to present CADI Discovery at the Connexion R&D conference organized by COSMETIC-VALLEY the leading Perfumery & Cosmetic cluster in France.

  • 2016: ANNOUNCEMENT August 1, 2016: BIO-MODELING SYSTEMS' novel Parkinson's therapy mentioned in a Report Covering 179 Companies. A new recognition of CADI Discovery capability to generate novel therapeutic strategies in complex human diseases of which CNS

  • 2016: Updated: Inaugural Presentation Bio-Entrepreneur 2015: The future will be digital and biology, but who will lead? Google? Watson? Alone or MDs, Physiologists, Biologists educating and mastering them combining diagnostics, therapies, connected devices and IT technologies?
Bio-Modeling Systems: The Mechanisms-Based Mecidicine Companys

BMSystems Professional Network

BMSystems expertise recognition: Memberships in prestigious international scientific, professional and evaluation committees

  • Member: Evaluation committee of the funding priorities in the "Medical Systems Biology- MedSys" program, German Federal ministry of Research Berlin (2008-) .
  • Expert Systems biology for the European Commission DG Research (2011-).  
  • Member: Scientific Committee of the Cambridge Healthtech Institute. The world leading scientific conferences organizer USA (2005-).
  • Member: Wellcome Trust's Board of Experts, Systems Biology. The world's largest medical research charity funding research into human and animal health U. K. (2001-).
  • Elected Member: Human Genome Organization (HUGO) (USA) (1994-).
  • Overseas Fellow: Medical Research Council (MRC) U.K. (1989-).
  • Member: Biotechnology Industry Organization (BIO) USA (2008-).

BMSystems expertise recognition: Memberships in prestigious national scientific, professional and evaluation committees

  • President: Centrale-Santé Leading healthcare and biotech Think Tank in France (1996-).
  • President Adebiotech:Leading biotech (scientific) Association in France (2006-).
  • Vice-President: Leem Biotech;  Biotech group of the pharma industry association in France (2003-).
  • Executive Committee member: Medicen Paris Region: "World class" healthcare and biotech cluster.
  • Member: Systematic Paris Region:"World class" French Information & Communication Technologies Cluster .
  • Member: Biotech-Pharma; The Association of the Bio-Pharma industry operating in France (Amgen, Actelion, Serono, Biogen-Idec, Gilead, Genzyme).
  • Educational contribution: Ecole Supérieure de Physique et Chimie Industrielle ESPCI).
  • Educational contribution: INSERM.
Bio-Modeling Systems: a leading Integrative Heuristic Systems Biology / Predictive Integrative Biology Mechanisms-Based Medicine company that delivers body> body> body> body> body> body> body>